LAUSR

Abstract Transition metal oxide nanomaterials (TMOs) have been adopted to produce reactive oxygen species (ROS) and adjust tumor microenvironment (TME) in cancer therapy. However, mono-modal treatment and the incompatibility of biological enzyme both hampered the therapeutic effect. Herein, we developed a multimodal TMO-based nanoplatform that the ultrathin Ti3C2 nanosheets were attached onto the MnFe2O4 nanoparticles self-assembled by applying chitosan as a chemical crosslinker to construct an interfacial Schottky junction, Ti3C2@Chitosan-MnFe2O4 (TC@Ch-MFO), achieving improved ROS generation as well as optimized biocompatibility. This heterojunction can controllably catalyze hydrogen peroxide (H2O2) to generate O2 and deplete the overexpressed glutathione (GSH) levels in hypoxic TME, which realizes the chemodynamic therapy (CDT) by cyclized Fenton reaction under NIR excitation. TC@Ch-MFO also constructs a multimodal treatment nanoplatform by introducing available high-efficiency photothermal agent (PTA), Ti3C2, for phtotheraml therapy (PTT). In addition, it simultaneously integrates the visualization with T1- and T2-weighting magnetic resonance imaging (MRI). The toxicity of TC@Ch-MFO to normal tissue cells is negligible. This platform could provide new insights into the development of multimoded synergistic nanoplatform for biological applications, especially breaking the shackles of MXenes merely used as a photo-thermal agent, adopting it to bioimaging sensor and drug loading.